Laboratory Medicine Program

Melanoma

Clinical Decription:
Multiple gene biomarker panel for Melanoma. Testing is indicated for advanced or metastatic disease. Next generation sequencing is used to detect sequence variants, copy number changes and gene fusions with diagnostic, prognostic and/or therapeutic utility. The test targets genes with utility for cutaneous melanoma and also genes with utility for uveal melanoma.

Method: Next-Generation Sequencing (NGS)

Component Tests Used: n/a

Reference Ranges Used:
Reference ranges for this test are not available online. However, they are included in all test results. For more information, please call us.

Specimen Type: Paraffin-embedded material (FFPE)/Cytology fluids
Volume: n/a

Shipping: room temperature or 4C

Special Instructions: Gene (BRAF, KIT, GNAQ, NRAS, BAP1, BRAF, CDK4, CDK6, CDKN2A, EIF1AX, GNA11, GNAQ, HRAS, KIT, NRAS, SF3B1) See requisitions for the full list of available testing and special instructions.

Testing Schedule(s): Please call

Turnaround Time: None

For more information, call 416.340.5227 or 1.866.865.5227